Publications dans lesquelles il/elle collabore avec JORGE LUIS TOLIVIA FERNANDEZ (21)

2024

  1. Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients

    International journal of molecular sciences, Vol. 25, Núm. 8

2021

  1. Avieyamientu: alzheimer y Apo D

    Ciencies. Cartafueyos Asturianos de Ciencia y Teunoloxía: Revista de la Academia de la Llingua Asturiana, Núm. 11, pp. 48-73

  2. Cuprizone‐induced neurotoxicity in human neural cell lines is mediated by a reversible mitochondrial dysfunction: Relevance for demyelination models

    Brain Sciences, Vol. 11, Núm. 2, pp. 1-16

  3. Neuroprotective effect of apolipoprotein d in cuprizone-induced cell line models: A potential therapeutic approach for multiple sclerosis and demyelinating diseases

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-23

2018

  1. Expression pattern of Myelin-Related Apolipoprotein D in human multiple sclerosis lesions

    Frontiers in Aging Neuroscience, Vol. 10, Núm. AUG

2017

  1. Propuesta de intervención para la mejora del aprendizaje en las prácticas de Biología Celular e Histología

    X Jornadas de Innovación Docente 2017: Redes para la innovación: la participación del alumnado

  2. Relación entre los estilos de aprendizaje y el éxito académico en las prácticas de Biología Celular e Histología del grado de Medicina (PAINN-16-029)

    X Jornadas de Innovación Docente 2017: Redes para la innovación: la participación del alumnado

2016

  1. Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?

    Journal of Alzheimer's Disease, Vol. 53, Núm. 2, pp. 639-650

  2. Regional and gender study of neuronal density in brain during aging and in alzheimer's disease

    Frontiers in Aging Neuroscience, Vol. 8, Núm. SEP

2015

  1. Apolipoprotein D subcellular distribution pattern in neuronal cells during oxidative stress

    Acta Histochemica, Vol. 117, Núm. 6, pp. 536-544

2013

  1. Aging and substitutive hormonal therapy influence in regional and subcellular distribution of ERα in female rat brain

    Age, Vol. 35, Núm. 3, pp. 821-837

  2. Highly selective and fast diagnosis of alzheimer's disease hallmark lesions using congo red in isopropyl alcoholic solution

    Journal of Alzheimer's Disease, Vol. 35, Núm. 3, pp. 589-597

  3. Lifelong Expression of Apolipoprotein D in the Human Brainstem: Correlation with Reduced Age-Related Neurodegeneration

    PLoS ONE, Vol. 8, Núm. 10

  4. Oxidative stress induces apolipoprotein d overexpression in hippocampus during aging and alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 36, Núm. 1, pp. 129-144

2012

  1. Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment

    Age, Vol. 34, Núm. 4, pp. 895-904

  2. Amyloid-β25-35 induces apolipoprotein D synthesis and growth arrest in HT22 hippocampal cells

    Journal of Alzheimer's Disease, Vol. 30, Núm. 2, pp. 233-244

  3. Gender differences in apolipoprotein D expression during aging and in Alzheimer disease

    Neurobiology of Aging, Vol. 33, Núm. 2, pp. 433.e11-433.e20

2010

  1. ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury

    GLIA, Vol. 58, Núm. 11, pp. 1320-1334

  2. Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan

    Age, Vol. 32, Núm. 1, pp. 85-96

2008

  1. Apolipoprotein d expression absence in degenerating neurons of human central nervous system

    Histology and Histopathology, Vol. 23, Núm. 8, pp. 995-1001